Challenges for Urologic Research: Moving Biomarkers into Practice

Forum

Molecular Biomarkers for Prostate Cancer Detection and Prognosis: Decision Aids or Decision Made?

Sunday, May 20
9:45 AM - 10:05 AM
Location: MCC SOUTH, 208

Daniel W. Lin

University of Washington

Dr. Lin is Professor and Chief of Urologic Oncology in the Department of Urology, the Director of the Institute for Prostate Cancer Research, and holds the Pritt Family Endowed Chair in Prostate Cancer Research at the University of Washington School of Medicine. Dr. Lin received his undergraduate degree from Stanford University and his medical degree from Vanderbilt University. He completed his urology residency at the University of Washington and urologic oncology fellowship at Memorial Sloan-Kettering Cancer Center, followed by an American Foundation for Urologic Disease (AFUD) Physician Scholar Award at the Fred Hutchinson Cancer Research Center.

Dr. Lin’s major basic/translational research interests are in molecular/genomic biomarkers for aggressive prostate cancer, and his major clinical research efforts are in prostate cancer active surveillance and novel strategies in high-risk prostate cancer. Dr. Lin serves on various national committees including the guideline panels for the National Comprehensive Cancer Network (NCCN) and the American Urological Association (AUA). Dr. Lin was Chair of the Male Genital Panel for the American Joint Commission on Cancer (AJCC) 8th Edition. Dr. Lin is co-Chair of the Prostate Cancer Task Force of the NCI GU Steering Committee and is Chair of the Localized Prostate Cancer Committee for the Southwest Oncology Group (SWOG). Dr. Lin receives funding from multiple peer-reviewed grants from the National Cancer Institute (NCI) and Department of Defense (DOD).

Presentation(s):

Send Email for Daniel Lin


Assets

Molecular Biomarkers for Prostate Cancer Detection and Prognosis: Decision Aids or Decision Made?



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Molecular Biomarkers for Prostate Cancer Detection and Prognosis: Decision Aids or Decision Made?